Rhenman & Partners Asset Management AB logo

Rhenman & Partners Asset Management AB Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Rhenman & Partners Asset Management AB with $903.7M in long positions as of Q3 2025, 98% allocated to Healthcare, and 30% concentrated in top 10 positions.

Portfolio Value
$903.7M
Top 10 Concentration
30%
Top Sector
Healthcare (98%)
US Exposure
95%
Market Cap Focus
Large Cap
Countries
7

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 98.30%Healthcare
Healthcare
98.30%

Industry Breakdown

10 industries across all sectors

Biotechnology: 33.04%BiotechnologyMedical - Devices: 18.53%Medical - DevicesMedical - Healthcare Plans: 10.52%Medical - Healthcare PlansDrug Manufacturers - General: 9.69%Drug Manufacturers - GeneralMedical - Diagnostics & Research: 8.40%Medical - Diagnostics & ResearchMedical - Distribution: 6.06%4 more: 12.07%4 more
Biotechnology
Healthcare
33.04%
Medical - Devices
Healthcare
18.53%
Medical - Healthcare Plans
Healthcare
10.52%
Drug Manufacturers - General
Healthcare
9.69%
Medical - Diagnostics & Research
Healthcare
8.40%
Medical - Distribution
Healthcare
6.06%
Medical - Instruments & Supplies
Healthcare
4.34%
Medical - Care Facilities
Healthcare
3.26%
Drug Manufacturers - Specialty & Generic
Healthcare
2.63%
Medical - Healthcare Information Services
Healthcare
1.83%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 11.70%Mega Cap (> $200B)Large Cap ($10B - $200B): 52.86%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 23.71%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 7.89%Micro Cap ($50M - $300M): 0.62%Nano Cap (< $50M): 2.16%N/A (ETF or Unknown): 1.06%
Mega Cap (> $200B)
11.70%
Large Cap ($10B - $200B)
52.86%
Mid Cap ($2B - $10B)
23.71%
Small Cap ($300M - $2B)
7.89%
Micro Cap ($50M - $300M)
0.62%
Nano Cap (< $50M)
2.16%
N/A (ETF or Unknown)
1.06%

Portfolio Concentration

Top 10 Holdings %
30.09%
Top 20 Holdings %
51.0%
Top 50 Holdings %
85.2%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
94.61%
International
5.39%
Countries
7
Largest Int'l Market
Ireland - 3.86%
United States of America
94.61% ($854.9M)
84 holdings
Ireland
3.86% ($34.9M)
3 holdings
Netherlands
0.56% ($5.0M)
1 holdings
Canada
0.36% ($3.3M)
1 holdings
United Kingdom
0.31% ($2.8M)
1 holdings
Switzerland
0.16% ($1.5M)
1 holdings
Italy
0.15% ($1.3M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
25.4 quarters
Avg. Top 20
24 quarters
Avg. All Positions
14.2 quarters
Median Holding Period
8.5 quarters
Persistence Rate
71.74%
Persistent Holdings Weight
85.73%
Persistent Positions
66
Longest Held
Alkermes Inc. plc logo
Alkermes Inc. plcALKS - 47 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.38%
Avg. Position Weight
1.09%
Largest Position
Boston Scientific Corp. logo
Boston Scientific Corp.BSX - 4.73%
Largest Ownership Stake
Anteris Technologies Global Corp. Common Stock logo
Anteris Technologies Global Corp. Common StockAVR - 3.47%
Avg. Ownership Stake
0.15%
Ownership Stake >5%
0
Ownership Stake >1%
1

Historical (Since Q4 2013)

Avg. New Position
0.97%
Avg. Ownership Stake
0.16%
Largest Position
Align Technology Inc logo
Align Technology IncALGN - 24.69% (Q3 2023)
Largest Ownership Stake
Anteris Technologies Global Corp. Common Stock logo
Anteris Technologies Global Corp. Common StockAVR - 3.59% (Q1 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
21.7%
Value Traded
$196.14M
Positions Added
10
Positions Exited
11

Historical (Since Q4 2013)

Avg. Turnover Ratio
19.8%
Avg. Positions Added
8
Avg. Positions Exited
9
Highest Turnover
50.0%
Q4 2013
Lowest Turnover
8.3%
Q3 2020

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.